ストックスクリーナーアプリを入手
5.77
7.97%
-0.50
アフターアワーズ：
5.79
0.02
+0.35%
前日終値:
$6.27
開ける：
$6.08
24時間の取引高:
211.86K
Relative Volume:
0.31
時価総額：
$6.30M
収益：
-
当期純損益:
$-22.71M
株価収益率:
-0.4927
EPS:
-11.71
ネットキャッシュフロー:
$-18.24M
1週間 パフォーマンス:
-39.96%
1か月 パフォーマンス:
-31.88%
6か月 パフォーマンス:
-60.21%
1年 パフォーマンス:
-94.87%
1日の値動き範囲:
$5.73
$6.2216
1週間の範囲:
$5.73
$9.8908
52週間の値動き範囲:
$5.73
$129.50
Genprex Inc Stock (GNPX) Company Profile
GNPX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
5.77 | 6.30M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-01-26 | 開始されました | National Securities | Buy |
| 2019-04-29 | 開始されました | Noble Capital Markets | Outperform |
Genprex Inc (GNPX) 最新ニュース
How Genprex Inc. stock responds to policy changesStock Surge & AI Based Buy and Sell Signals - newser.com
Tools to monitor Genprex Inc. recovery probability2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Can Genprex Inc. (2DE0) stock sustain margin levelsJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
How to integrate Genprex Inc. into portfolio analysis toolsGold Moves & Expert Approved Trade Ideas - newser.com
What indicators show strength in Genprex Inc.2025 Top Decliners & Technical Pattern Recognition Alerts - newser.com
Backtesting results for Genprex Inc. trading strategiesWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
Can Genprex Inc. (2DE0) stock reach $200 price targetSwing Trade & Daily Stock Momentum Reports - newser.com
Can Genprex Inc. (2DE0) stock stage a strong rebound this quarterJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Why Genprex Inc. stock is popular among millennialsJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Will Genprex Inc. stock deliver consistent dividends2025 Big Picture & High Win Rate Trade Alerts - newser.com
Will Genprex Inc. stock reach Wall Street targetsEarnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com
Is Genprex Inc. stock ready for a breakout2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Can technical indicators confirm Genprex Inc.’s reversalQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
How institutional ownership impacts Genprex Inc. stockJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
How Genprex Inc. (2DE0) stock reacts to Fed tightening2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Why analysts recommend Genprex Inc. (2DE0) stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
What technical models suggest about Genprex Inc.’s comebackJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - newser.com
Why OUTFRONT Media Inc. stock attracts strong analyst attention - newser.com
Genprex Inc. stock retracement – recovery analysisQuarterly Earnings Summary & High Yield Equity Trading Tips - newser.com
Why Genprex Inc. stock remains undervaluedTreasury Yields & Community Verified Trade Alerts - newser.com
Genprex, Inc.Common Stock (NQ: GNPX - FinancialContent
Genprex Announces Securities Purchase Agreement and Offering - TipRanks
Genprex sells 377,780 shares; issues warrants up to 755,560 - Stock Titan
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Eastern Progress
Genprex Inc (GNPX) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):